期刊文献+

超敏C反应蛋白和冠状动脉造影术确定的冠心病冠脉病变严重程度相关性的直线回归分析 被引量:4

Correlation between high sensitive C-reactive protein with presence and extent of angiographically verified coronary artery disease by linear regression analysis
下载PDF
导出
摘要 目的探讨血浆超敏C反应蛋白(hs-CRP)水平与冠心病发病和通过冠脉造影确定的病变的严重程度的关系。方法选择江苏省人民医院住院行冠状动脉造影术的707例患者,采用Gensini评分计算冠脉造影积分,入院后分别测定患者的血清hs-CRP水平。采用SPSS15.0统计软件进行直线回归分析。结果直线回归分析结果CRP的回归系数B值为0.104,P<0.001。结论血浆hs-CRP水平与冠心病冠脉病变的严重程度高度相关。hs-CRP和动脉粥样硬化的严重程度密切相关。 Objective To explore the correlation between plasma high sensitive C-reactive protein (hs-CRP) levels and occurrence and extent of angiographically verified coronary artery dis- ease. Method A total of 707 patients who were admitted to Jiangsu Provincial People's Hospital and have accomplished coronary angiography were included in the study. Their coronary angiogra- phy scores were calculated by C, ensini score system. Plasma hs-CRP levels and other clinic indexes were detected. SPSS15.0 was adopted to conduct linear regression analysis. Result By linear re- gression, we obtained B value of hs-CRP (B = 0. 104, P 〈 0. 001 ). Conclusion There was strong correlation among plasma hs-CRP levels and occurrence and extent of coronary artery disease. Hs- CRP can not only indicate antherosclerosis, but also significantly associate with extent of an- therosclerosis.
出处 《实用临床医药杂志》 CAS 2012年第17期25-27,共3页 Journal of Clinical Medicine in Practice
关键词 超敏C反应蛋白 冠心病 冠状动脉造影积分 high sensitive C-reactive protein coronary artery disease coronary angiogra-phy scores
  • 相关文献

参考文献14

  • 1Tracy R P. Inflammation in cardiovascular disease[J]. Circu-lation, 1998; 97: 2000.
  • 2Inoue N. Vascular C-reactive protein in the pathogenesis ofcoronary artery disease:role of vascular inflammation and ox-idative vstresws[j]. Cardiovasc Hematol Disord Drug Targets,2006,6(4): 227.
  • 3Plutzky J. Inflammatory pathways in atherosclerosis and a-cute coronary syndromes[J]. Am J Cardiol, 2001,88: 10k.
  • 4Pietila K O,Harmoinen A P, Jokiniitty J J, et al. Serum C-reactive protein concentration in acute myocardial infarctionand its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment [J] . Eur Heart J,1999, 17: 1345.
  • 5Torres J L, Ridker P M. Clinical use of high-sensitivity C~re-active protein for the prediction of adverse cardiovascularevents[J]. Curr Opin Cardiol, 2003,18(6): 471.
  • 6Ridker P M, Cushman M, Stampfer M J, Tracy R P, Hen-nekens C H. Inflammation, aspirin, and the risk of cardio-vascular disease in apparently healthy men[j]. N Eng J Med,1997,336: 973.
  • 7Ridker P M,Buring J E, Shih J, Matias M, Hennekens CH. Prospective study of Oreactive protein and the risk of fu-ture cardiovascular events among apparently healthy women[J]. Circulation, 1998, 98: 731.
  • 8Taniguchi H, Momiyama Y, Ohmori R, Yonemura A, Ya-mashita T, Tamai S, et al. Associations of plasma C-reactiveprotein levels with the presence and extent of coronary steno-sis in patients with stable coronary artery disease [ J].Atherosclerosis, 2005,178: 173.
  • 9Azar R. R, Aoun G, Fram D B, et al. Relation of C-reactiveprotein to extent and severity of coronary narrowing in pa-tients with stable angina pectoris or abnormal exercise tests[J]. Am. J. Cardiol, 2000, 86: 205.
  • 10Aziz N, Fahey JL, Detels R, et al. Analytical performance ofa highly sensitive C-reactive protein-based immunoassay andthe effects of laboratory variables on levels of protein in blood[J]. Clin. Diagn. Lab. Immunol, 2003,10: 652.

同被引文献19

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部